GO:0055001 muscle cell development: Myogenesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0055001 (muscle cell development) describes the progression of a muscle cell from its formation to its mature structure, explicitly excluding the initial fate-commitment step.
• The term covers skeletal, cardiac and smooth muscle cell development, each with distinct transcriptional programs and morphological transitions.
• Key regulators include the myogenic determination factors MYOD1, MYF5, MYOG and MRF4, which drive myoblast differentiation and myofiber formation.
• Single-nucleus RNA-seq has revealed unexpected transcriptional heterogeneity among nuclei within multinucleated skeletal myofibers, refining how maturation is defined.
• Muscle cell development is central to regenerative medicine, congenital myopathies, sarcopenia and cardiovascular disease research.
• CRISPR-based knockout, knock-in and overexpression models enable causal testing of candidate genes at each stage of muscle cell development.
Description
Muscle cell development (GO:0055001) is the biological process by which a muscle cell progresses over time from its formation to its mature structure, without including the steps that commit an unspecified cell to the muscle cell fate. This distinction matters because it separates early lineage specification from the subsequent morphological and molecular maturation events that produce functional contractile cells. The term encompasses skeletal myogenesis, cardiomyocyte maturation and smooth muscle cell development, each governed by overlapping but distinct regulatory networks. Understanding GO:0055001 is therefore essential for researchers studying development, regeneration and disease. Defects in muscle cell development underlie congenital myopathies, impaired cardiac maturation and vascular remodeling, and the process is also reactivated or dysregulated in acquired conditions such as atherosclerosis and cancer cachexia. Because the term is defined by outcome rather than by a single gene, it is studied using a combination of lineage tracing, single-cell and single-nucleus transcriptomics, imaging and functional perturbation. This article summarizes the authoritative QuickGO definition, the major stages and regulators of muscle cell development, and the experimental and CRISPR-based methods used to interrogate it.
muscle cell development At A Glance
| GO ID | GO:0055001 |
|---|---|
| GO term | muscle cell development |
| Ontology | biological_process |
| Synonym | muscle fiber development; muscle fibre development; myofiber development; myofibre development |
| Definition | The process whose specific outcome is the progression of a muscle cell over time, from its formation to the mature structure; excludes commitment of an unspecified cell to the muscle cell fate. |
| Major function | Generation of mature, functional contractile muscle cells from committed muscle progenitors. |
| Scope | Includes skeletal, cardiac and smooth muscle cell development. |
| Excluded step | Commitment of an unspecified cell to the muscle cell fate. |
| Related processes | Myoblast differentiation, myofiber maturation, sarcomere assembly and muscle regeneration. |
What Is GO:0055001?
According to the QuickGO definition, muscle cell development is the process whose specific outcome is the progression of a muscle cell over time, from its formation to the mature structure. Importantly, the definition states that muscle cell development does not include the steps involved in committing an unspecified cell to the muscle cell fate. In practice, this means the term begins after a progenitor has already adopted a muscle identity and covers the subsequent events, such as myoblast elongation, fusion, sarcomere assembly and metabolic maturation, that generate a mature contractile cell.
Why Is muscle cell development Important in Cell Biology?
Muscle cell development is important because it determines the number, type and functional capacity of muscle cells in every contractile tissue, and its disruption produces disease. Skeletal muscle development defects cause congenital myopathies and impair regeneration after injury, while abnormal cardiac muscle cell maturation limits the utility of stem cell-derived cardiomyocytes for disease modeling and therapy. Smooth muscle cell development and transdifferentiation contribute to vascular remodeling and atherosclerosis, where altered smooth muscle cell states drive lipid accumulation and plaque instability. In addition, perivascular adipose tissue lineages and muscle cell communication pathways influence metabolic and repair processes, linking muscle cell development to obesity, diabetes and tissue regeneration. Because the process is genetically tractable and can be modeled in vitro, it is a productive area for CRISPR-based functional genomics.
• Provides the cellular basis for skeletal muscle formation, growth and regeneration after injury.
• Underlies cardiac muscle cell maturation, which is critical for stem cell-derived cardiomyocyte applications.
• Governs smooth muscle cell development and transdifferentiation in vascular disease and atherosclerosis.
• Its dysregulation contributes to congenital myopathies and other inherited muscle disorders.
• Muscle cell communication pathways are essential for coordinated development and repair.
• Single-nucleus transcriptomics has revealed heterogeneity within mature myofibers, refining maturation markers.
• New muscle cell lines from non-model species expand comparative and aquaculture-relevant research.
• Perivascular adipose tissue lineage studies connect muscle-related developmental programs to metabolic disease.
• CRISPR screens can identify novel regulators of myoblast differentiation and myofiber maturation.
• The process is a target for regenerative medicine, gene therapy and drug discovery.
What Happens During muscle cell development?
Myoblast differentiation and myocyte formation
In simple terms: Committed muscle precursor cells stop dividing and start building the machinery of a muscle cell.
After fate commitment, myoblasts exit the cell cycle and initiate a differentiation program driven by myogenic regulatory factors such as MYOD1 and MYF5, followed by MYOG and MRF4. These transcription factors activate muscle-specific genes, including those encoding contractile proteins and metabolic enzymes, and drive the morphological transition from mononucleated myoblasts to elongated myocytes. This step is a defining early phase of GO:0055001 because it represents progression toward the mature muscle cell rather than the initial commitment event.
Myoblast fusion and multinucleated myofiber formation
In simple terms: Many small muscle cells merge into one long cell with multiple nuclei, which is the building block of skeletal muscle.
Skeletal muscle development proceeds through fusion of mononucleated myoblasts into multinucleated myofibers, a process requiring coordinated membrane remodeling and cytoskeletal reorganization. The resulting myofibers contain many nuclei sharing a common cytoplasm, and single-nucleus RNA-seq has shown that these nuclei are transcriptionally heterogeneous, with distinct subpopulations specialized for different functions. This heterogeneity is now considered an important feature of mature myofiber identity and is relevant to how muscle cell development is assessed experimentally.
Sarcomere assembly and contractile maturation
In simple terms: The cell organizes its contractile proteins into repeating units that allow it to generate force.
As muscle cells mature, contractile proteins are assembled into sarcomeres, the repeating structural and functional units of striated muscle. Sarcomere assembly requires precise stoichiometry of actin, myosin and associated proteins, and its completion marks a key transition toward the mature muscle cell structure described by GO:0055001. In cardiac muscle, maturation also involves changes in ion channel expression, calcium handling and metabolic substrate preference, which together define the mature cardiomyocyte phenotype.
Smooth muscle cell development
In simple terms: Muscle cells in blood vessels and organs develop a different, non-striated contractile program.
Smooth muscle cell development in vertebrates arises from multiple embryonic origins and is regulated by a distinct set of transcription factors and signaling pathways compared with skeletal and cardiac muscle. Smooth muscle cells retain considerable plasticity, and under pathological conditions they can transdifferentiate and accumulate lipids, contributing to atherosclerosis. Cellular communication network factor 2 (CCN2) has been shown to regulate smooth muscle cell transdifferentiation and lipid accumulation in atherosclerosis, illustrating how developmental programs can be reactivated in disease.
Muscle cell communication during development and repair
In simple terms: Muscle cells talk to their neighbors to coordinate growth and healing.
Muscle cell development does not occur in isolation; muscle cells communicate with surrounding cells through secreted factors, extracellular matrix interactions and direct contact. These communication pathways are important both during development and during repair after injury, and they influence how muscle cells mature and integrate into tissue. Perivascular adipose tissue lineage studies have further shown that developmental origins and cell-cell signaling shape the cellular composition of muscle-associated tissues, with implications for metabolic disease.
Key Genes Involved in GO:0055001 muscle cell development
The following genes and proteins are central to muscle cell development and are commonly studied using CRISPR-based perturbation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYOD1 | Myogenic determination factor; activates muscle-specific genes | Core regulator of myoblast differentiation |
| MYF5 | Myogenic determination factor; early myoblast specification | Frequently studied in skeletal myogenesis |
| MYOG | Promotes myoblast fusion and terminal differentiation | Key marker and driver of myofiber formation |
| MRF4 | Myogenic regulatory factor; supports late differentiation | Studied in muscle maturation |
| MYH1 | Myosin heavy chain isoform in fast skeletal muscle | Marker of mature myofiber identity |
| MYH7 | Myosin heavy chain isoform in cardiac and slow muscle | Relevant to cardiac and skeletal muscle maturation |
| ACTA1 | Skeletal muscle actin; sarcomere component | Target for sarcomere assembly studies |
| TNNT2 | Cardiac troponin T; regulates contraction | Studied in cardiomyocyte maturation |
| CCN2 | Regulates smooth muscle cell transdifferentiation and lipid accumulation | Linked to atherosclerosis |
| MYOCD | Master regulator of smooth muscle cell differentiation | Central to smooth muscle development |
| SRF | Serum response factor; cooperates with myogenic factors | Required for muscle gene expression |
| MEF2C | Transcription factor enhancing muscle differentiation | Studied in skeletal and cardiac muscle |
| PAX7 | Satellite cell marker; supports postnatal muscle growth | Relevant to regeneration |
| DES | Desmin; intermediate filament in muscle cells | Structural marker of muscle maturation |
| TTN | Titin; sarcomere scaffold protein | Studied in sarcomere assembly and myopathy |
| CDH2 | N-cadherin; mediates cell-cell adhesion during fusion | Studied in myoblast fusion |
| CAV3 | Caveolin-3; membrane protein in muscle cells | Linked to muscle membrane organization |
How Is muscle cell development Regulated?
Muscle cell development is regulated by a hierarchical transcriptional network in which MYOD1 and MYF5 initiate the program and MYOG and MRF4 drive terminal differentiation and fusion. These factors cooperate with broadly expressed cofactors such as MEF2C and SRF to activate muscle-specific enhancers. Signaling inputs from cell-cell communication pathways, including secreted factors and extracellular matrix interactions, modulate the timing and extent of differentiation during development and repair. In smooth muscle, a distinct regulatory module centered on MYOCD controls differentiation, and pathological transdifferentiation can be influenced by factors such as CCN2. Postnatal growth and regeneration depend on satellite cells marked by PAX7, which re-enter the myogenic program after injury. Together, these layers of regulation ensure that muscle cell development is coordinated with tissue demand and environmental signals.
muscle cell development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ACTA1 | Congenital myopathy with sarcomere defects | Knockout or point-mutation in muscle cell line |
| TTN | Titin-related myopathy and cardiomyopathy | Knock-in of patient variants in myoblasts |
| CCN2 | Atherosclerosis and smooth muscle transdifferentiation | Overexpression or knockout in smooth muscle cells |
| MYOCD | Smooth muscle differentiation disorders | Knockout in vascular smooth muscle models |
| TNNT2 | Cardiomyopathy and impaired cardiac maturation | Knock-in in stem cell-derived cardiomyocytes |
Congenital and inherited muscle disorders
Disruption of muscle cell development causes congenital myopathies and other inherited muscle disorders characterized by weakness and structural abnormalities. Mutations in sarcomeric and structural genes such as ACTA1, TTN and DES impair sarcomere assembly and myofiber maturation, linking the developmental process directly to disease. Understanding these defects requires models that recapitulate the progression from myoblast to mature myofiber.
Cardiovascular and smooth muscle disease
Smooth muscle cell development and plasticity contribute to vascular disease, including atherosclerosis, where smooth muscle cells can transdifferentiate and accumulate lipids. CCN2 has been implicated in regulating this transdifferentiation and lipid accumulation, highlighting a potential therapeutic target. Abnormal cardiac muscle cell maturation also limits the use of stem cell-derived cardiomyocytes for disease modeling and regenerative therapy.
Metabolic and regenerative conditions
Muscle cell communication pathways are essential for repair after injury, and their failure contributes to impaired regeneration. Perivascular adipose tissue lineage studies have connected developmental programs in muscle-associated tissues to metabolic disease, including obesity-related pathology. These links make muscle cell development relevant to regenerative medicine and metabolic research.
From muscle cell development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for myoblast differentiation? | CRISPR knockout in a skeletal myoblast line |
| Does a patient variant impair sarcomere assembly? | Point-mutation knock-in in myoblasts |
| Can a transcription factor drive maturation? | Overexpression in committed muscle progenitors |
| Where and when is a protein expressed during development? | Tagged knock-in with fluorescent reporter |
| Which genes regulate smooth muscle transdifferentiation? | CRISPR library screening in smooth muscle cells |
| How heterogeneous are nuclei within mature myofibers? | Single-nucleus RNA-seq of muscle tissue |
How to Study the muscle cell development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcript levels | Profiling differentiation stages |
| Single-nucleus RNA-seq | Transcriptional heterogeneity per nucleus | Studying multinucleated myofibers |
| Immunofluorescence | Protein localization and sarcomere structure | Validating maturation phenotypes |
| Live-cell imaging | Dynamic fusion and morphological changes | Tracking myoblast differentiation |
| CRISPR knockout | Loss-of-function effects | Testing gene requirement |
| CRISPR knock-in | Variant or tag effects | Modeling patient mutations |
| Overexpression | Gain-of-function effects | Testing sufficiency of regulators |
| Pooled CRISPR screen | Unbiased identification of regulators | Discovering novel developmental genes |
Transcriptomic profiling of muscle cell development
RNA-seq and single-nucleus RNA-seq are widely used to define transcriptional states during muscle cell development and to identify heterogeneity within mature myofibers. These approaches can resolve distinct nuclear subpopulations and reveal maturation-associated gene signatures. Comparative studies across species and cell lines further expand the reference datasets available for muscle research.
Imaging and morphological analysis
Immunofluorescence and live-cell imaging are used to visualize sarcomere assembly, myoblast fusion and myofiber morphology during development. These methods provide spatial and temporal information that complements transcriptomic data and can validate CRISPR-induced phenotypes.
Functional perturbation and screening
CRISPR knockout, knock-in and overexpression approaches allow causal testing of candidate genes at specific stages of muscle cell development. Pooled CRISPR screens can identify novel regulators of differentiation and maturation in an unbiased manner. Such screens are particularly useful for discovering genes that control smooth muscle transdifferentiation and lipid accumulation.
Lineage tracing and cell communication studies
Lineage tracing and cell communication assays reveal the developmental origins of muscle cells and their interactions with neighboring cell types. These methods are important for understanding how muscle cells integrate into tissues during development and repair.
How CRISPR Can Be Used to Study GO:0055001 muscle cell development
Knockout
CRISPR knockout is used to test whether a candidate gene is required for muscle cell development, for example by disrupting MYOD1, MYOG or sarcomeric genes in myoblast lines and assessing differentiation and fusion. Knockout of smooth muscle regulators such as MYOCD can reveal their role in smooth muscle cell development and transdifferentiation.
Point Mutation
Point-mutation knock-in allows modeling of patient-specific variants in genes such as ACTA1 or TTN to determine how subtle changes affect sarcomere assembly and myofiber maturation. This approach is valuable for distinguishing pathogenic variants from benign polymorphisms in muscle disease research.
Knock-in
Tagged knock-in of fluorescent or epitope tags enables visualization of endogenous proteins during muscle cell development, including nuclear subpopulations within myofibers. Knock-in can also be used to introduce lineage reporters that trace muscle cell origins and communication during development and repair.
Overexpression
Overexpression of transcription factors or signaling molecules can test whether a gene is sufficient to drive or enhance muscle cell maturation. For example, overexpression of CCN2 in smooth muscle cells can model its effects on transdifferentiation and lipid accumulation in atherosclerosis.
How EDITGENE Supports muscle cell development Research
Researchers studying muscle cell development-related genes often need to determine whether a candidate gene is causally involved in differentiation, fusion or maturation, and this requires precise, reproducible genetic models. EDITGENE provides end-to-end CRISPR services that enable such causal testing across skeletal, cardiac and smooth muscle cell systems.
Contact EDITGENE today to design your custom CRISPR model for muscle cell development research.
Frequently Asked Questions About muscle cell development
What is GO:0055001 muscle cell development?
GO:0055001 is the biological process describing the progression of a muscle cell from its formation to the mature structure, excluding the initial commitment of an unspecified cell to the muscle cell fate.
What genes are involved in muscle cell development?
Key genes include MYOD1, MYF5, MYOG, MRF4, MYOCD, MEF2C, SRF, ACTA1, TTN and CCN2, among others.
Does muscle cell development include fate commitment?
No, the QuickGO definition explicitly excludes the steps involved in committing an unspecified cell to the muscle cell fate.
What are the synonyms of GO:0055001?
Synonyms include muscle fiber development, muscle fibre development, myofiber development and myofibre development.
How is muscle cell development studied?
It is studied using RNA-seq, single-nucleus RNA-seq, imaging, lineage tracing and CRISPR-based perturbation.
What is the role of MYOD1 in muscle cell development?
MYOD1 is a myogenic determination factor that activates muscle-specific gene expression during differentiation.
How do smooth muscle cells develop?
Smooth muscle cells arise from multiple embryonic origins and are regulated by factors such as MYOCD, with plasticity relevant to atherosclerosis.
Can CRISPR be used to study muscle cell development?
Yes, CRISPR knockout, knock-in and overexpression models allow causal testing of genes at each stage of muscle cell development.
What diseases are linked to defects in muscle cell development?
Congenital myopathies, cardiomyopathies and atherosclerosis are among the conditions linked to disrupted muscle cell development.
Why is single-nucleus RNA-seq important for muscle research?
It reveals transcriptional heterogeneity among nuclei within multinucleated myofibers, refining our understanding of maturation.
Conclusion
GO:0055001 muscle cell development defines the maturation of muscle cells from committed progenitors to functional contractile cells, spanning skeletal, cardiac and smooth muscle lineages. Its regulation by myogenic transcription factors, signaling pathways and cell-cell communication makes it a rich area for developmental and disease research. CRISPR-based models and single-cell technologies now allow precise interrogation of this process, supporting discoveries relevant to myopathies, cardiovascular disease and regenerative medicine.
References
- 1. Demonbreun AR et al.. 2017. Muscle cell communication in development and repair.. Curr Opin Pharmacol 34:7-14 PMID: 28419894
- 2. Donadon M et al.. 2021. The origin and mechanisms of smooth muscle cell development in vertebrates.. Development 148(7) PMID: 33789914
- 3. Xu Q et al.. 2024. Cellular communication network factor 2 regulates smooth muscle cell transdifferentiation and lipid accumulation in atherosclerosis.. Cardiovasc Res 120(17):2191-2207 PMID: 39365752
- 4. Chal J et al.. 2017. Making muscle: skeletal myogenesis in vivo and in vitro.. Development 144(12):2104-2122 PMID: 28634270
- 5. Petrany MJ et al.. 2020. Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers.. Nat Commun 11(1):6374 PMID: 33311464
- 6. Goswami M et al.. 2025. Development and characterization of a new muscle cell line developed from pearl spot, Etroplus suratensis (Bloch 1790).. Res Vet Sci 196:105880 PMID: 40957357
- 7. Angueira AR et al.. 2021. Defining the lineage of thermogenic perivascular adipose tissue.. Nat Metab 3(4):469-484 PMID: 33846639
- 8. Fijnvandraat AC et al.. 2003. Development of heart muscle-cell diversity: a help or a hindrance for phenotyping embryonic stem cell-derived cardiomyocytes.. Cardiovasc Res 58(2):303-12 PMID: 12757865
